Source: Eur Respir J 2009; 33: 502-508
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Pujols L., Benitez P., Alobid I., Martinez-Anton A., Roca-Ferrer J., Mullol J., Picado C.. Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo. Eur Respir J 2009; 33: 502-508

Member's Comments

No comment yet.

Related content which might interest you: Cox-2 regulation by IL-1β through MAPKs: A comparison of nasal mucosa and nasal polyps fibroblasts from AIA patients Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Increased COX-1 and COX-2 mRNA expression and prostaglandin E2 production by dendritic cells from patients with asthma Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production Year: 2003 Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps Source: Eur Respir J 2004; 24 : 594-600 Year: 2004 Anti-proliferative and anti-inflammatory effect of glucocorticoids in nasal mucosa and nasal polyp fibroblasts Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Regulation of E-cadherin expression by dexamethasone and tumour necrosis factor-α in nasal epithelium Source: Eur Respir J 2002; 20: 1430-1436 Year: 2002 NOTCH-1 activation sustains hyperexpression of IL-33 in the epithelium of nasal polyps Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 IL-13 induces glucocorticoid resistance in iNOS expression and activity in human airway epithelial cells (HAECs) Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Increased expression of IL-19 in metaplastic epithelium of patients with chronic rhinosinusitis and nasal polyps Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells Source: Eur Respir J 2012; 39: 439-445 Year: 2012 Effects of TNF-alpha on the human nasal mucosa in vivo Source: Eur Respir J 2006; 28: Suppl. 50, 672s Year: 2006 Role of IL-13Ra2 in modulating IL-13 induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019 Chemokine expression, apoptosis, and proliferation in the airway mucosa at steroid-mediated resolution of allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 32s Year: 2003 Inducible NOS overexpression is related to lymphocyte-driven inflammation in bronchial mucosa of smokers Source: Eur Respir J 2003; 22: Suppl. 45, 549s Year: 2003 Glucocorticoids and indacaterol regulated gene expressions profiling in human bronchial epithelial cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33 Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 Lipopolysacharide modulates glucocorticoid receptor function in nasal mucosa and polyp fibroblasts Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Bronchial thermoplasty may increase steroid sensitivity by upregulating the expression of the glucocorticoid receptor Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Metformin regulates sirtuin expression in airway epithelial cells Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Differential expression of mRNA encoding for pro-inflammatory and angiogenic proteins in aspirin-tolerant and -intolerant asthma, following oral provocative aspirin challenge Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009